R-954

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameR-954
Drug Alias Namepainful diabetic neuropathy therapy (Genesis Biopharma)bradykinin antagonists (Universities of Ferrara/Sherbrooke)painful diabetic neuropathy therapy (Genesis Biopharma/ SciMeDent)R-954R-715
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionBradykinin B1 receptor antagonists
TargetsBradykinin B1 receptor
Therapy Area/IndicationsPainInflammationDiabetes Complications +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Sherbrooke
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSciMeDent Health CorpUniversity of FerraraTransferTech Co Ltd +[5] 
Active IndicationsN/A
Inactive IndicationsPainInflammationDiabetes Complications +[4] 

Other Information

ATC CodeN/A
Related LinksN/A